Search results
Lilly Endowment Inc sells over $64 million in Eli Lilly stock By Investing.com
Investing.com· 3 days agoIn a recent transaction, Lilly Endowment Inc, a substantial shareholder in Eli Lilly & Co...
Eli Lilly and Company (NYSE:LLY) Stock Price Up 0.8% Following Analyst Upgrade
ETF DAILY NEWS· 4 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) rose 0.8% during trading on Monday after Jefferies Financial Group raised their price target on the stock from $925.00 to ...
Is Eli Lilly the Best Pharmaceutical Stock for You? | The Motley Fool
The Motley Fool· 2 days agoEli Lilly (LLY 1.85%) stock has soared 90% over the past year, a huge gain for a pharmaceutical...
Eli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 75,510 Shares
ETF DAILY NEWS· 2 days agoEli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 75,510 shares of Eli Lilly and Company stock in a transaction ...
FDA Panel Backs Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 4 days agoThe panel later voted unanimously that the benefits of donanemab outweigh the risks for the types of...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 3 days agoEli Lilly stock is trading at a record high as enthusiasm grows for its Alzheimer's treatment,...
'Our boy is coming back to Omaha': Elkhorn family cheers on son playing in the CWS
KMTV 3 News Now Omaha· 14 hours agoIt's an unplanned visit home for University of Kentucky freshman, Eli Small. His family shares what...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 3 days agoEli Lilly became the most valuable health-care company in the world on the back of its blockbuster...
Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
Investor's Business Daily· 3 days agoEli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's...
Eli Lilly Pushes Alzheimer's Stocks Lower On FDA Win
Investor's Business Daily· 3 days agoDespite the stock move, analysts largely expect donanemab to gain FDA approval. Late Monday, the advisors to the FDA voted unanimously that the clinical...